Opendata, web and dolomites

Al-medicare

Disruptive Artificial Intelligence engine to facilitate rapid low cost development of specialist e-health applications for smart decision making in medical pre-diagnosis

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Al-medicare project word cloud

Explore the words cloud of the Al-medicare project. It provides you a very rough idea of what is the project "Al-medicare" about.

b2b    infermedica    party    recommends    first    15    disruption    few    saving    platform    attractive    conduct    lives    misdiagnosed    services    healthcare    people    3rd    techniques    experts    clinical    share    vcs    10    months    least    ai    shortage    lack    practices    foundation    individual    apps    business    time    life    digital    market    workers    base    ups    practitioners    engines    complete    model    provides    validate    05    co    founders    providers    building    rarity    solution    start    ehr    machine    1000    framework    refine    environment    countries    developers    adapt    medical    companies    money    rely    mainly    decision    global    learning    toolset    innovation    expand    commercialize    performance    unfortunately    strategy    significantly    medicare    patients    optimize    engage    public    takes    diagnostic    diagnosis    health    limited    license    professional    thousands    demonstration    al    cooperation   

Project "Al-medicare" data sheet

The following table provides information about the project.

Coordinator
INFERMEDICA SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA 

Organization address
address: PLAC SOLNY 14/3
city: WROCLAW
postcode: 50-062
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Poland [PL]
 Project website http://infermedica.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.4. (Active ageing and self-management of health)
2. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.3.1.6. (Health care provision and integrated care)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2017
 Duration (year-month-day) from 2017-02-01   to  2017-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    INFERMEDICA SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA PL (WROCLAW) coordinator 50˙000.00

Map

 Project objective

10-15% of all medical cases in developed countries are misdiagnosed, mainly due to medical practitioners’ lack of experience, limited time for diagnosis and rarity of the conditions. Furthermore, there is an increasing global shortage of healthcare workers. WHO recommends at least 2.3 health workers per 1000 people, unfortunately yet some countries have 0.05 per 1000 people. To address this need, Infermedica has developed a medical diagnostic framework AI-medicare which for the first time provides a complete toolset for 3rd party developers of medical apps and services to build advanced clinical decision support systems. Our solution enables digital health developers to achieve at low cost and short time what currently takes months, saving thousands of lives and public money. To do so, co-founders rely on their cooperation with professional partners, medical experts, and VCs. Today there are just a few companies which try to develop diagnostic engines to improve clinical decision-making. However, they do it without meaningful disruption of current medical practices, and they do not share their AI engines. For that, Al-medicare open medical platform is particularly attractive for IT companies building healthcare products or services for patients and providers like research institutions, EHR platform providers, start-ups and individual developers. To fully commercialize this EU-based technology, a comprehensive business model was proposed. Future growth will be driven by B2B model based on the license. In Phase 1, we will conduct global market studies of the digital health market, develop an innovation management strategy and identify and engage development and demonstration partners. In Phase 2, we will significantly expand and refine the medical knowledge base which is the foundation of the framework, validate and test the diagnostic framework in a real-life environment and adapt advanced machine learning techniques to expand and optimize AI-medicare performance.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "AL-MEDICARE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "AL-MEDICARE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.4.;H2020-EU.2.1.1.;H2020-EU.2.3.1.;H2020-EU.3.1.6.)

CLINICOVERY (2018)

CLINICOVERY, a versatile, high quality, environmental-friendly, easy to use e-Clinical solution for clinical research

Read More  

ImmuneHunter (2017)

Bioinformatics platform for profiling of health: allowing early and accurate detection of multiple diseases simultaneously

Read More  

SensUS (2018)

SensUS: A non-invasive and quantitative ultrasound (QUS) device for an objective monitoring of the childbirth labour process.

Read More